• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑肽酶对[精氨酸8]加压素(AVP)代谢产物的形成。中间产物[半胱氨酸6]AVP-(3-9)的转化。

Formation of metabolites of [Arg8]vasopressin (AVP) by brain peptidases. Conversion of the intermediate [Cyt6]AVP-(3-9).

作者信息

Wang X C, Burbach J P

出版信息

FEBS Lett. 1986 Mar 3;197(1-2):164-8. doi: 10.1016/0014-5793(86)80319-2.

DOI:10.1016/0014-5793(86)80319-2
PMID:3949012
Abstract

[Cyt6]AVP-(3-9), an intermediate in the metabolism of AVP-(1-9) in vitro, was used to investigate the mechanism of formation of centrally active AVP metabolites. Exposure of [Cyt6]AVP-(3-9) to rat brain membranes resulted in formation of [Cyt6]AVP-(4-9), -(5-9), [pGlu4, Cyt6]AVP-(4-9) and AVP-(3-5), which were isolated and chemically identified. Products derived from cleavage of the C-terminus of the substrate were absent. Time-course experiments further indicated that the conversion process is predominantly mediby an aminopeptidase-like mechanism. The conversion of [Cyt6]AVP-(3-9) by membranes from hippocampus, amygdala and septum was quantitatively and qualitatively similar. The results point to a major role of aminopeptidase activity in the metabolic conversion of AVP and the formation of centrally active AVP metabolites.

摘要

[Cyt6]精氨酸加压素-(3-9)是精氨酸加压素-(1-9)体外代谢的中间产物,用于研究中枢活性精氨酸加压素代谢产物的形成机制。将[Cyt6]精氨酸加压素-(3-9)与大鼠脑膜一起孵育,结果形成了[Cyt6]精氨酸加压素-(4-9)、-(5-9)、[焦谷氨酸4,Cyt6]精氨酸加压素-(4-9)和精氨酸加压素-(3-5),这些产物经过分离和化学鉴定。未发现底物C末端裂解产生的产物。时间进程实验进一步表明,转化过程主要由一种氨肽酶样机制介导。海马、杏仁核和隔区的膜对[Cyt6]精氨酸加压素-(3-9)的转化在数量和质量上相似。结果表明氨肽酶活性在精氨酸加压素的代谢转化和中枢活性精氨酸加压素代谢产物的形成中起主要作用。

相似文献

1
Formation of metabolites of [Arg8]vasopressin (AVP) by brain peptidases. Conversion of the intermediate [Cyt6]AVP-(3-9).脑肽酶对[精氨酸8]加压素(AVP)代谢产物的形成。中间产物[半胱氨酸6]AVP-(3-9)的转化。
FEBS Lett. 1986 Mar 3;197(1-2):164-8. doi: 10.1016/0014-5793(86)80319-2.
2
Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membranes. Characterization of formed peptides and mechanisms of proteolysis.脑突触膜对精氨酸加压素和催产素的蛋白水解转化。生成肽的特性及蛋白水解机制。
J Biol Chem. 1983 Feb 10;258(3):1487-94.
3
Proteolytic conversion of oxytocin by brain synaptic membranes: role of aminopeptidases and endopeptidases.
Peptides. 1991 Sep-Oct;12(5):1119-25. doi: 10.1016/0196-9781(91)90068-z.
4
Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.血管加压素和催产素C末端片段对大鼠回避行为的构效关系研究。
J Pharmacol Exp Ther. 1987 Apr;241(1):268-74.
5
No. 302, a newly synthesized [pGlu4,Cyt6]AVP(4-9) analogue, prevents the disruption of avoidance behavior.
Behav Brain Res. 1997 Feb;83(1-2):205-8. doi: 10.1016/s0166-4328(97)86070-6.
6
Effect of vasopressin, oxytocin and peptides derived from these hormones on field potential induced in lateral septum of rats by stimulation of the fimbria fornix.
Neuropeptides. 1986 Jan;7(1):41-9. doi: 10.1016/0143-4179(86)90078-8.
7
Vasopressin anti-idiotypic antibody staining in the rat brain: colocalization with [35S] [pGlu4, Cyt6]AVP(4-9) binding sites.
J Neuroendocrinol. 1993 Oct;5(5):523-31. doi: 10.1111/j.1365-2826.1993.tb00517.x.
8
Kinetics of circulating vasopressin uptake by choroid plexus.
Am J Physiol. 1991 Feb;260(2 Pt 2):F216-24. doi: 10.1152/ajprenal.1991.260.2.F216.
9
Comparative effects of arginine vasopressin, [pGlu4,Cyt6]arginine vasopressin-(4-9) and nerve growth factor on maintenance of functional tolerance to ethanol in mice.精氨酸加压素、[焦谷氨酸4,胞嘧啶6]精氨酸加压素-(4-9)和神经生长因子对小鼠乙醇功能耐受性维持的比较作用。
Eur J Pharmacol. 1991 Jun 18;199(1):131-4. doi: 10.1016/0014-2999(91)90649-b.
10
Effects of arginine vasopressin on protein phosphorylation in rat hippocampal synaptic membranes.精氨酸加压素对大鼠海马突触膜蛋白磷酸化的影响。
J Neurosci Res. 1987;17(1):71-9. doi: 10.1002/jnr.490170111.